ADVANCED PHARMACOLOGY
COMPREHENSIVE EXAMINATION
QUESTIONS AND ANSWERS. 2026
VERIFIED
1. A patient is prescribed Lisinopril for hypertension. Which mechanism best describes how
this medication lowers blood pressure?
A. It blocks the binding of Angiotensin II to its receptors.
B. It acts as a competitive antagonist at beta-1 adrenergic receptors.
C. It increases the excretion of sodium by blocking the sodium-potassium pump.
D. It inhibits the conversion of Angiotensin I to Angiotensin II.
Answer: D
Conceptual Explanation: Lisinopril is an ACE inhibitor, which prevents the conversion of
Angiotensin I to Angiotensin II, a potent vasoconstrictor and stimulator of aldosterone.
2. Which of the following laboratory parameters must be monitored most closely when a
patient is initiated on Amiodarone therapy?
A. Hemoglobin A1c and fasting glucose
B. Serum creatinine and blood urea nitrogen
,C. Thyroid stimulating hormone (TSH) and liver function tests
D. Serum calcium and magnesium levels
Answer: C
Conceptual Explanation: Amiodarone is rich in iodine and can cause thyroid dysfunction
(both hypo- and hyperthyroidism) and hepatotoxicity, requiring regular TSH and LFT
monitoring.
3. A patient taking Warfarin (Coumadin) is diagnosed with a urinary tract infection and
prescribed Sulfamethoxazole/Trimethoprim (Bactrim). What is the most likely outcome of
this drug interaction?
A. Decreased anticoagulant effect of Warfarin
B. Increased risk of therapeutic failure of the antibiotic
C. Increased INR and higher risk of bleeding
D. No significant interaction is expected
Answer: C
Conceptual Explanation: Bactrim inhibits the metabolism of Warfarin and displaces it
from protein binding sites, leading to an increased INR and elevated bleeding risk.
4. Why are non-selective beta-blockers, such as Propranolol, generally contraindicated in
patients with symptomatic asthma?
A. They cause excessive mucus production in the bronchioles.
, B. They can cause bronchoconstriction by blocking beta-2 receptors.
C. They inhibit the cough reflex, leading to pneumonia.
D. They decrease the effectiveness of inhaled corticosteroids.
Answer: B
Conceptual Explanation: Non-selective beta-blockers antagonize both beta-1 (cardiac)
and beta-2 (pulmonary) receptors. Blocking beta-2 receptors leads to bronchoconstriction.
5. A patient is presenting with tremors, confusion, and a serum lithium level of 2.2 mEq/L.
Which of the following is the most appropriate next step?
A. Continue current dose and recheck in 24 hours.
B. Increase fluid intake and slightly increase lithium dose.
C. Hold the lithium and initiate hydration/stabilization.
D. Switch to Valproic acid immediately without tapering.
Answer: C
Conceptual Explanation: A lithium level of 2.2 mEq/L is toxic (therapeutic range is
usually 0.6-1.2 mEq/L). The drug must be held to prevent further toxicity and organ
damage.
6. Which teaching point is essential for a patient starting Atorvastatin (Lipitor)?
A. Expect the urine to turn a bright orange color.
B. Take the medication with a glass of grapefruit juice to increase absorption.
COMPREHENSIVE EXAMINATION
QUESTIONS AND ANSWERS. 2026
VERIFIED
1. A patient is prescribed Lisinopril for hypertension. Which mechanism best describes how
this medication lowers blood pressure?
A. It blocks the binding of Angiotensin II to its receptors.
B. It acts as a competitive antagonist at beta-1 adrenergic receptors.
C. It increases the excretion of sodium by blocking the sodium-potassium pump.
D. It inhibits the conversion of Angiotensin I to Angiotensin II.
Answer: D
Conceptual Explanation: Lisinopril is an ACE inhibitor, which prevents the conversion of
Angiotensin I to Angiotensin II, a potent vasoconstrictor and stimulator of aldosterone.
2. Which of the following laboratory parameters must be monitored most closely when a
patient is initiated on Amiodarone therapy?
A. Hemoglobin A1c and fasting glucose
B. Serum creatinine and blood urea nitrogen
,C. Thyroid stimulating hormone (TSH) and liver function tests
D. Serum calcium and magnesium levels
Answer: C
Conceptual Explanation: Amiodarone is rich in iodine and can cause thyroid dysfunction
(both hypo- and hyperthyroidism) and hepatotoxicity, requiring regular TSH and LFT
monitoring.
3. A patient taking Warfarin (Coumadin) is diagnosed with a urinary tract infection and
prescribed Sulfamethoxazole/Trimethoprim (Bactrim). What is the most likely outcome of
this drug interaction?
A. Decreased anticoagulant effect of Warfarin
B. Increased risk of therapeutic failure of the antibiotic
C. Increased INR and higher risk of bleeding
D. No significant interaction is expected
Answer: C
Conceptual Explanation: Bactrim inhibits the metabolism of Warfarin and displaces it
from protein binding sites, leading to an increased INR and elevated bleeding risk.
4. Why are non-selective beta-blockers, such as Propranolol, generally contraindicated in
patients with symptomatic asthma?
A. They cause excessive mucus production in the bronchioles.
, B. They can cause bronchoconstriction by blocking beta-2 receptors.
C. They inhibit the cough reflex, leading to pneumonia.
D. They decrease the effectiveness of inhaled corticosteroids.
Answer: B
Conceptual Explanation: Non-selective beta-blockers antagonize both beta-1 (cardiac)
and beta-2 (pulmonary) receptors. Blocking beta-2 receptors leads to bronchoconstriction.
5. A patient is presenting with tremors, confusion, and a serum lithium level of 2.2 mEq/L.
Which of the following is the most appropriate next step?
A. Continue current dose and recheck in 24 hours.
B. Increase fluid intake and slightly increase lithium dose.
C. Hold the lithium and initiate hydration/stabilization.
D. Switch to Valproic acid immediately without tapering.
Answer: C
Conceptual Explanation: A lithium level of 2.2 mEq/L is toxic (therapeutic range is
usually 0.6-1.2 mEq/L). The drug must be held to prevent further toxicity and organ
damage.
6. Which teaching point is essential for a patient starting Atorvastatin (Lipitor)?
A. Expect the urine to turn a bright orange color.
B. Take the medication with a glass of grapefruit juice to increase absorption.
